Arthritis care announced support for new treatment Barchester Healthcare In 2010, Nice recommended tocilizumab as a means of treating people with arthritis if there has been an inadequate response to one or more TNF inhibitors and where rituximab has also produced inadequate response. The drug was also recommended where ... |
